Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rahul Chaudhry"'
Autor:
Lindsay L. Puckett, Shahryar G. Saba, Sonia Henry, Stacey Rosen, Elise Rooney, Samaria L. Filosa, Philip Gilbo, Karalyn Pappas, Alison Laxer, Katherine Eacobacci, Amitha N. Kapyur, Justin Robeny, Samantha Musial, Anisha Chaudhry, Rahul Chaudhry, Martin L. Lesser, Adam Riegel, Sariah Ramoutarpersaud, Navid Rahmani, Amar Shah, Vivian Papas, Toluwani Dawodu, Jessica Charlton, Jonathan P. S. Knisely, Lucille Lee
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5051-5061 (2021)
Abstract Background Long‐term breast cancer survivors are at risk for cardiotoxicity after treatment, but there is insufficient evidence to provide long‐term (~10 years) cardiovascular disease (CVD) screening recommendations. We sought to evaluat
Externí odkaz:
https://doaj.org/article/7f2d2311877f4184a396cc0e0442aed7
Autor:
Justin Robeny, Shahryar G. Saba, Vivian Papas, Alison Laxer, Sonia Henry, Lindsay Puckett, Samantha Musial, Philip Gilbo, Toluwani Dawodu, Anisha Chaudhry, Samaria L Filosa, Navid Rahmani, Martin Lesser, Adam C. Riegel, Elise Rooney, L. Lee, Amar Shah, Karalyn Pappas, Katherine Eacobacci, Amitha N Kapyur, Stacey E. Rosen, Sariah Ramoutarpersaud, Jonathan P.S. Knisely, Jessica Charlton, Rahul Chaudhry
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 15, Pp 5051-5061 (2021)
Cancer Medicine, Vol 10, Iss 15, Pp 5051-5061 (2021)
Background Long‐term breast cancer survivors are at risk for cardiotoxicity after treatment, but there is insufficient evidence to provide long‐term (~10 years) cardiovascular disease (CVD) screening recommendations. We sought to evaluate a tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd92b2fe0001a5094d04c1b50daee691
https://doi.org/10.1002/cam4.4037
https://doi.org/10.1002/cam4.4037
Autor:
Rahul Chaudhry
Publikováno v:
Pharmaceutical Patent Analyst. 5:401-406
This article deals with compulsory licensing scenarios in India, provides a background of relevant provisions in the Patents Act and examines how these provisions are Trade-Related Aspects of Intellectual Property Rights compliant. This article furth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e30de219e7ba3172df29ed3d814abaf
https://doi.org/10.4155/ppa-2016-0033
https://doi.org/10.4155/ppa-2016-0033
Autor:
Alison Laxer, Shahryar G. Saba, Karalyn Pappas, Rahul Chaudhry, Samantha Musial, Jessica Charlton, Samaria L Filosa, Sariah Ramoutarpersaud, Sonia Henry, Katherine Eacobacci, Philip Gilbo, Elise Rooney, Amitha N Kapyur, Anisha Chaudhry, Adam C. Riegel, Lindsay Puckett, L. Lee, Justin Robeny, Martin Lesser, Stacey E. Rosen
Publikováno v:
Journal of Clinical Oncology. 37:11569-11569
11569 Background: Long-term breast cancer survivors are at risk of late effects from cardiotoxic (tox) radiation (RT) and chemotherapy (chemo). However, there is a paucity of data to recommend appropriate cardiac screening for those ~10 years (yrs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c7e04c783c315ea8093312789159762
https://doi.org/10.1200/jco.2019.37.15_suppl.11569
https://doi.org/10.1200/jco.2019.37.15_suppl.11569